Acorda Therapeutics CEO Ron Cohen Appointed Member of Executive Committee of Biotechnology Industry Organization (BIO)
HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (NASDAQ: ACOR) today announced President and CEO Ron Cohen, M.D. has been appointed to the Executive Committee of the Biotechnology Industry Organization (BIO). Dr. Cohen was also named Vice Chair of the Emerging Companies Section of BIO. BIO is the world's largest biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide.